相关实验视频

Updated: May 9, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

瘤微环境中的CircRNAs的免疫调节行为

Haisu Liang^1,2, Wei Yan³, Zhi Liu^1,4

¹Department of Urology, Xiangya Hospital, Central South University, Changsha, 410000, China.

Oncology research

|April 29, 2025

概括

循环RNAs (circRNAs) 是稳定的分子,调节瘤免疫微环境 (TME). 它们影响免疫细胞功能,影响癌症免疫力和潜在的治疗方法.

科学领域:

分子生物学分子生物学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

循环RNA (circRNAs) 是一种具有稳定的循环结构,耐降解的非编码RNA.
瘤微环境 (TME) 的组成部分,包括免疫细胞,显著影响瘤的发展和进展.
循环RNAs的失调与各种疾病有关,特别是癌症,它们在TME中调解免疫反应.

研究的目的:

审查circRNAs在调节瘤免疫微环境 (TME) 中的作用.
要突出 circRNAs,特别是外体 circRNAs,如何影响免疫细胞行为和抗瘤免疫力.
讨论circRNA-TME相互作用对瘤免疫调节和免疫治疗的影响.

主要方法:

文献综述侧重于瘤免疫微环境中的circRNA功能.
在调节免疫细胞分化,化疗和功能方面分析circRNA机制.
检查影响circRNA介导免疫反应的因素,包括代谢重编程,缺氧和病毒感染.

主要成果:

来自瘤和TME细胞的circRNAs作为免疫反应和逃避的关键媒介.
循环RNAs,特别是在外体内,直接和间接调节免疫细胞,影响抗瘤免疫力.
代谢重编程,缺氧和病毒感染被确定为影响circRNA驱动瘤免疫力的因素.

结论:

循环RNAs在塑造瘤免疫微环境和影响抗瘤免疫力方面发挥着关键作用.
了解circRNA-TME相互作用为新的治疗策略提供了潜力,包括免疫检查点疗法.
外体circRNAs为向癌症免疫疗法提供了一个有前途的途径.

关键词:

循环RNA (循环RNA) 是一种循环RNA.免疫反应的免疫反应.代谢重编程是一种代谢重编程.瘤是一个瘤.瘤微环境 (TME) 是指瘤的微环境.

更多相关视频

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.